Clinical Trial Update: Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis [Phase 2]

View source ↗

Summary

Phase II pilot trial evaluating cyclophosphamide plus rabbit anti-thymocyte globulin as salvage therapy in diffuse systemic sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Cytoxan (cyclophosphamide) (cyclophosphamide)
• Thymoglobulin (rabbit anti-thymocyte globulin) (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Systemic Sclerosis | Phase 2 | Status: COMPLETED